Skip to content

BIAFW BIOAFFINITY TECHNOLOGIES INC

Follow

*W EXP 09/07/202 (warrant or right), issuer CIK 1712762

3 managers (3 13F filers) reported a position in BIAFW shares at 2025-12-31, 125,088 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.

Managers
3
13F filers
3
New
0
Added
0
Reduced
3
Sold out
0
Shares held by filers
125,088

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2025

Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Clear Street Group Inc.in group Clear Street Group Inc.55,041$19.3K<0.01%-27913F-HRTimelineGroup
UBS Group AGin group UBS Group AG46,549$16.3K<0.01%-1,12013F-HRTimelineGroup
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC23,498$7.75K<0.01%-7,08613F-HRTimelineGroup